Accessibility Menu
 
GlobeStar Therapeutics logo

GlobeStar Therapeutics

(OTC) GSTC

Current Price$0.00
Market Cap$1,200
Since IPO (2016)-100%
5 Year-100%
1 Year-100%
1 Month+0%

GlobeStar Therapeutics Financials at a Glance

Market Cap

$1,200

Revenue (TTM)

$0.00

Net Income (TTM)

$888.00K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-29.83 (Low)

Price

$0.00

Volume

4,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

GSTC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GlobeStar Therapeutics

Industry

Biotechnology

CEO

James C. Katzaroff

Headquarters

Richland, WA 99352, US

GSTC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

1%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.20K

Shares Outstanding

1.24B

Volume

4.00K

Short Interest

0.00%

Avg. Volume

4.64K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.86M

EBITDA

$6.72K

Operating Cash Flow

$205.76K

Capital Expenditure

$0.00

Free Cash Flow

$205.76K

Cash & ST Invst.

$0.00

Total Debt

$366.00K

GlobeStar Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.20K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$198.00K

+84.6%

EBITDA

$357.00

-94.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$329.01K

-1972.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$329.05K

+1972.3%

Return on Assets

0.00%

N/A

Return on Invested Capital

1.30%

N/A

Free Cash Flow

$20.40K

+49.2%

Operating Cash Flow

$20.40K

+49.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBLAPanbela Therapeutics, Inc.
$0.00-96.08%
RGMPRegnum Corp.
$0.00+0.00%
ACUSAcusphere, Inc.
$0.00+0.00%
EHOSEhouse Global, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.86+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.46+0.00%
MARAMara Holdings
$10.04+0.05%
IBITiShares Bitcoin Trust
$40.96-0.01%

Questions About GSTC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.